Schonfeld Strategic Advisors’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
2023
Q3
$328K Buy
2023
Q1
Sell
2022
Q4
$263K Sell
2022
Q3
$5.57M Buy
2022
Q1
Sell
2021
Q4
$1.24M Sell
2021
Q3
$2.96M Buy
2021
Q2
$1.85M Buy
2021
Q1
$1.92M Buy